Active, not recruitingPhase 3NCT02859038

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

Studying Primary peritoneal carcinoma

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shanghai Gynecologic Oncology Group
Principal Investigator: Rongyu Zang, MD,PHD
Fudan University Shanghai Zhongshan Hospital
Intervention: Upfront cytoreductive surgery(procedure)
Enrollment: 489 enrolled
Eligibility: 18 years · FEMALE
Timeline: 2016 – 2027

Study locations (8)

Sun Yet-Sen University Cancer Center, Guangzhou, Guangdong, China
Zhongshan Hospital Fudan University, Shanghai, Shanghai Municipality, China
Shanghai First Maternity and Infant Hospital Affiliated to Tongji University, Shanghai, Shanghai Municipality, China
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Hunan Provincial Hospital, Changsha, China
Seoul National University Hospital, Seoul, South Korea
Ajou University Hospital, Suwon, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02859038 on ClinicalTrials.gov

Other trials for Primary peritoneal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Primary peritoneal carcinoma →

← Back to all trials